Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS20024401HPVENSG00000131759.18protein_codingRARANoNo5914A8MUP8
P10276
Q6I9R7
TVIS20021335HPVENSG00000131759.18protein_codingRARANoNo5914A8MUP8
P10276
Q6I9R7
TVIS44049649HTLV-1ENSG00000131759.18protein_codingRARANoNo5914A8MUP8
P10276
Q6I9R7
TVIS44049650HTLV-1ENSG00000131759.18protein_codingRARANoNo5914A8MUP8
P10276
Q6I9R7
TCGA Plot Options
Drug Information
GeneRARA
DrugBank IDDB12808
Drug NameTrifarotene
Target IDBE0000663
UniProt IDP10276
Regulation Typeagonist
PubMed IDs29974453
CitationsAubert J, Piwnica D, Bertino B, Blanchet-Rethore S, Carlavan I, Deret S, Dreno B, Gamboa B, Jomard A, Luzy AP, Mauvais P, Mounier C, Pascau J, Pelisson I, Portal T, Rivier M, Rossio P, Thoreau E, Vial E, Voegel JJ: Nonclinical and human pharmacology of the potent and selective topical retinoic acid receptor-gamma agonist trifarotene. Br J Dermatol. 2018 Aug;179(2):442-456. doi: 10.1111/bjd.16719. Epub 2018 Jul 4.
GroupsApproved; Investigational
Direct ClassificationM-terphenyls
SMILESCC(C)(C)C1=CC(=CC=C1N1CCCC1)C1=CC(=CC=C1OCCO)C1=CC=C(C=C1)C(O)=O
Pathways
PharmGKB
ChEMBLCHEMBL3707313